ABT-414, an Antibody-Drug Conjugate Targeting a Tumor-Selective EGFR Epitope
Molecular Cancer Therapeutics (2016) - Comment
pubmed: 26846818  doi: 10.1158/1535-7163.mct-15-0901  issn: 1538-8514  issn: 1535-7163 

Andrew C. Phillips, Erwin R. Boghaert, Kedar S. Vaidya, Michael J. Mitten, Suzanne Norvell, Hugh D. Falls, Peter J. DeVries, Dong Cheng, Jonathan A. Meulbroek, Fritz G. Buchanan, Laura M. McKay, Neal C. Goodwin, Edward B. Reilly